Akt signal transduction dysfunction in Parkinson's disease

Area of Science:

• Neuroscience
• Molecular Biology
• Cellular Signaling

Background:

• The PI3-kinase-Akt (PKB) pathway's role in Parkinson's disease (PD) neurodegeneration is under investigation.
• Activation of Akt shows potential for neuroprotection in PD.
• The integrity of the Akt system in PD remains largely unknown.

Purpose of the Study:

• To investigate the levels and localization of total and active Akt in the brains of Parkinson's disease patients.
• To determine if Akt signaling is defective in the dopaminergic neurons affected by PD.

Main Methods:

• Western blot analysis of midbrain fractions from PD and control brains.
• Immunofluorescence microscopy of the substantia nigra pars compacta (SNpc) to detect Akt and phospho-Akt.
• Double immunofluorescence staining for Akt, phospho-Akt, and tyrosine hydroxylase (TH) in dopaminergic neurons.

Main Results:

• Diminished levels of total and active phospho(Ser473)-Akt were observed in PD brains compared to controls.
• Akt and phospho-Akt were highly expressed in tyrosine hydroxylase (TH)-positive dopaminergic neurons in control brains.
• A marked decrease in Akt and phospho-Akt expression was found in dopaminergic neurons of PD brains, though still present in degenerating neurons.
• Increased Akt and phospho-Akt levels were detected in glial cells within the PD SNpc.

Conclusions:

• Defective Akt signaling is implicated as a potential pathway contributing to dopaminergic neuron loss in Parkinson's disease.
• The presence of Akt in degenerating neurons suggests potential therapeutic targeting in advanced PD.
• Altered Akt expression in glial cells indicates a broader involvement of this pathway in PD pathology.